NCT02951754View on ClinicalTrials.gov

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

PHASE4RecruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2032

Study Completion Date

December 31, 2032

Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
DRUG

Immediate-release Methylphenidate

Standard initial dose of 10 mg, twice or three times daily with doses increasing weekly until symptom control or occurrence of limiting adverse effects

Trial Locations (1)

90035-903

RECRUITING

Program on Attention-Deficit/Hyperactivity Disorder (PRODAH); Hospital de Clínicas de Porto Alegre, Porto Alegre

All Listed Sponsors
collaborator

Federal University of Rio Grande do Sul

OTHER

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

collaborator

Coordination for the Improvement of Higher Education Personnel

OTHER

lead

Hospital de Clinicas de Porto Alegre

OTHER